
Search SNP
Search Gene
Search CNV
Search Haplotype
Search Other Variant
Search Region
Search Pathway
Search Study
Gene Report
Basic information | Related studies | Functional annotation | Related other genetic factors | Overlap with SZ and MDD | ADD to My Gene Set | Comment on Gene | View All Comments on Gene |
Approved Symbol | BDNF |
---|---|
Approved Name | brain-derived neurotrophic factor |
Name Alias | neurotrophin |
Location | 11p14.1 |
Position | chr11:27654893-27722058, -1 |
External Links |
HGNC: 1033 Entrez Gene: 627 Ensembl: ENSG00000176697 UCSC: uc009yje.3 |
No. of Studies | 37 (Positive: 24; Negative: 12; trend: 1) |
Overlap with SZ? | YES |
Overlap with MDD? | YES |
Reference | Tested Markers | Statistical Values/Author Comments | Result Category | Comment on Study |
---|---|---|---|---|
Hong, C. J.,2003 | Other variant: BDNF_Val66Met | Given the fact that the positive association between BDNF gene Val66Met polymorphism and bipolar disorder has only been demonstrated for a Caucasian population but not for a Japanese analog or our Chinese sample, it appears likely that this association is ethnicity dependent. | Negative | Comment on Study |
Nakata, K.,2003(a) | Other variant: BDNF_-1360C>T, BDNF_196G/A | The results suggest that the BDNF gene is unlikely to confer susceptibility to BPD. | Positive | Comment on Study |
Sklar, P.,2002 | Other variant: BDNF_12910C/A, BDNF_-1480C/G, BDNF_3071G/A, BDNF_9202G/A, BDNF_11757C/G, BDNF_14569G/A, BDNF_196G/A, BDNF_-633T/A, BDNF_Val66Met | This study of 76 candidate genes has identified BDNF as a potential risk allele that will require additional study to confirm. | Positive | Comment on Study |
Neves-Pereira, M.,2002 | Haplotype: [BNDF_(GT)n] - (BNDF_val66met)(allele 10-A), [BNDF_(GT)n] - (BNDF_val66met)(allele 1-A), [BNDF_(GT)n] - (BNDF_val66met)(allele 1-G), [BNDF_(GT)n] - (BNDF_val66met)(allele 2-A), [BNDF_(GT)n] - (BNDF_val66met)(allele 2-G), [BNDF_(GT)n] - (BNDF_val66met)(allele 3-A), [BNDF_(GT)n] - (BNDF_val66met)(allele 3-G), [BNDF_(GT)n] - (BNDF_val66met)(allele 4-A), [BNDF_(GT)n] - (BNDF_val66met)(allele 4-G), [BNDF_(GT)n] - (BNDF_val66met)(allele 5-G), [BNDF_(GT)n] - (BNDF_val66met)(allele 7-G) Other variant: BDNF_(GT)n, BDNF_Val66Met |
Our results suggested that a DNA variant in the vicinity of the BDNF locus confers susceptibility to BP. | Positive | Comment on Study |
Kunugi, H.,2004 | Other variant: BDNF_Val66Met | The Val66Met polymorphism of the BDNF gene is unrelated to the development or clinical features of bipolar disorder, at least in a Japanese population. | Negative | Comment on Study |
Geller, B.,2004 | Other variant: BDNF_Val66Met | This finding in child bipolar disorder is consistent with data for adults with bipolar disorder that show preferential transmission of the Val66 allele. | Positive | Comment on Study |
Wang, Z.,2012 | SNP: rs6265 | Although these results should be interpreted with caution because of the limited sample for Val/Val genotype in BPD-II patients (N = 5), these findings strengthen the hypothesis that BDNF pathway gets involved in the etiology and pharmacology of BPD and suggest the differences between BPD-I and BPD-II. | Positive | Comment on Study |
Hamshere, M. L.,2012 | Other variant: BDNF_Val66Met | The significant interaction effect for the Val/Val genotype of the BDNF Val66Met polymorphism and A1/A2 genotype of DRD2/ANKK1 Taq1A polymorphism was found only in BP-II patients. We provide initial evidence that the BDNF Val66Me and DRD2/ANKK1 Taq1A polymorphisms interact only in BP-II disorder and that BP-I and BP-II are genetically distinct. | Positive | Comment on Study |
Schumacher, J.,2005 | SNP: rs6265, rs988748 Haplotype: rs988748 - BDNF_(GT)n - rs6265(C-166bp-G), rs988748 - BDNF_(GT)n - rs6265(C-168bp-G), rs988748 - BDNF_(GT)n - rs6265(C-170bp-G), rs988748 - BDNF_(GT)n - rs6265(C-172bp-G), rs988748 - BDNF_(GT)n - rs6265(C-174bp-G), rs988748 - BDNF_(GT)n - rs6265(G-170bp-A), rs988748 - BDNF_(GT)n - rs6265(G-174bp-A), rs988748 - BDNF_(GT)n - rs6265(G-174bp-G), rs988748 - BDNF_(GT)n - rs6265(G-176bp-A) Other variant: BDNF_(GT)n |
Our study does not lend much support to a role for BDNF in the etiopathogenesis of BPAD but at the same time cannot unequivocally rule it out. | Trend | Comment on Study |
Neves-Pereira, M.,2005 | SNP: rs6265 Haplotype: rs6265 - microsatellite (GT)n(A-(GT1)), rs6265 - microsatellite (GT)n(G-(GT1)) |
Haplotype analysis of val/met SNP and a dinucleotide repeat polymorphism in the putative promoter region revealed highly significant (P<E-08) under-representation of the methionine or met-1 haplotype in the schizophrenic but not the BP population. | Negative | Comment on Study |
Matsuo, K.,2009 | Other variant: BDNF_Val66Met | The findings support an association between the BDNF Val66Met genotype and differential gray matter content in brain structures, and suggest that the variation in this gene may play a more prominent role in brain structure differences in subjects affected with BD. | Positive | Comment on Study |
Chepenik, L. G.,2009 | Other variant: BDNF_Val66Met | In sum, this study of the val66met polymorphism provides preliminary evidence that variation in BNDF has the potential to influence hippocampus structure in BD, and carriers of the met allele may be a subgroup within BD more vulnerable to hippocampus-related deficits. | Positive | Comment on Study |
Sears, C.,2011 | SNP: rs10835210, rs11030104, rs11030107, rs11030119, rs12273363, rs1519480, rs6265, rs7103873 | Our results support the hypothesis that some BDNF gene polymorphisms may be contributing factors in the pathogenesis of BD. | Positive | Comment on Study |
Neves, F. S.,2011 | SNP: rs2049045, rs4923463, rs6265, rs7103411 | No genotypic, allelic or haplotype differences were found between bipolar patients and healthy controls. | Negative | Comment on Study |
Hosang, G. M.,2010 | SNP: rs6265 | The Met containing genotype of BNDF gene was significantly associated with BD. | Positive | Comment on Study |
Soronen, P.,2011 | SNP: rs11030102 | No significant association of this gene was observed in BD. | Negative | Comment on Study |
Okada, T., 2006 | Haplotype: BDNF_LCPR - BDNF_Val66Met(A1-Val ), BDNF_LCPR - BDNF_Val66Met(A2-Val ), BDNF_LCPR - BDNF_Val66Met(A3-Val ), BDNF_LCPR - BDNF_Val66Met(A4-Val ), BDNF_LCPR - BDNF_Val66Met(A4-Met ), BDNF_LCPR - BDNF_Val66Met(A5-Val ), BDNF_LCPR - BDNF_Val66Met(A5-Met ) Other variant: BDNF-LCPR |
Our results suggest that the BDNF-LCPR is a functional variation that confers susceptibility to bipolar disorder and affects transcriptional activity of the BDNF gene. | Positive | Comment on Study |
Skibinska, M., 2004 | Other variant: BDNF_Val66Met | No association was found between the studied polymorphism and schizophrenia or bipolar affective disorder either for genotype or allele distribution. | Negative | Comment on Study |
Huang, C. C.,2012 | Other variant: BDNF_Val66Met | BDNF Val/Va: logistic Regression P-value=0.82, OR=1.10, 95% CI=0.47-2.60 in BPI, P-value=0.04, OR=0.40, 95% CI=0.16-0.97 in BPII, BDNF Val/Met: logistic Regression P-value=0.33, OR=1.18, 95% CI=0.54-2.58 in BPI, P-value=0.36, OR=1.39, 95% CI=0.69-2.80 in BPII. Multiple logistic regression analysis, controlled for age and gender, showed a significant main effect of the Val/Val genotype on the BDNF Val66Met gene in the BP-II group. | Positive | Comment on Study |
Liu, L., 2008 | SNP: rs11030104, rs12273363, rs1519480, rs2030324, rs2883187, rs6265, rs7103411, rs7127507, rs7934165, rs988748 | Evidence of association (p<0.05) was found with several of the SNPs using multiple models of bipolar disorder; one of these SNPs also showed evidence of association (p<0.05) with rapid cycling.. These results provide further evidence that variation in BDNF affects the risk for bipolar disorder. | Positive | Comment on Study |
Tang, J., 2008 | Other variant: BDNF_C270T, BDNF_Val66Met | The study demonstrates that the BDNF C-270T and Val66Met polymorphisms are unlikely to contribute to the genetic predisposition to BPD as a whole. But Val66Met may be associated with susceptibility to the early age of onset subset of the disorder. | Negative | Comment on Study |
Vincze, I., N., 2008 | Haplotype: BDNF-LCPR - A-633T - G196A(STG ), BDNF-LCPR - A-633T - G196A(SAG ), BDNF-LCPR - A-633T - G196A(LAA ), BDNF-LCPR - A-633T - G196A(LAG ), BDNF-LCPR - A-633T - G196A(SAA ), BDNF-LCPR - A-633T - G196A(STA ), BDNF-LCPR - A-633T - G196A(LTG ) Other variant: BDNF_196G/A, BDNF_A-633T, BDNF-LCPR |
BDNF G196A (Val66Met) genotypic P-value = 0.0071; Allelic P-value = 0.12. We replicated the association previously reported between BDNF G196A (Val66Met) polymorphism and BD | Positive | Comment on Study |
Oswald, P., 2004 | SNP: rs6265 Haplotype: g.196A_ g.11757G() Other variant: BDNF_g.11757C>G |
We failed to replicate previous findings implicating BDNF in the aetiology of BPAD | Negative | Comment on Study |
Chang, Y. H.,2013 | Other variant: BDNF_Val66Met | The involvement of the dopaminergic pathway in AD was confirmed, particularly with BP-II rather than BP-I. Because the Val/Val genotype of the BDNF Val66Met polymorphism, rather than the other two polymorphisms, has been associated with anxiety, it seems to affect BP-I comorbid with AD without the involvement of the DRD3 Seg9Gly polymorphism, but may modify the involvement of DRD3 Gly/Gly in BP-II comorbid with AD. | Positive | Comment on Study |
Lee, S. Y.,2012(a) | Other variant: BDNF_Val66Met | We provide initial evidence that the BDNF Val66Met and DRD3 Ser9Gly genotypes interact only in bipolar-II disorder and that bipolar-I and bipolar-II may be genetically distinct. | Positive | Comment on Study |
Lee, S. Y.,2012(b) | Other variant: BDNF_Val66Met | Our findings provide initial evidence that the COMT and BDNF genes interact in bipolar-II without AD. Our findings suggest the involvement of dopaminergic pathway in the pathogenesis of bipolar-II. | Positive | Comment on Study |
Ivanova, M. A.,2012 | SNP: rs6265, rs16917237, rs12273363 Haplotype: rs6265 - rs16917237(C-G), rs16917237 - rs12273363(G-T), rs6265 - rs16917237 - rs12273363(C-G-T), rs16917237 - rs12273363(T-T) |
In summary, the current study lends support to the role of BDNF as a predisposing or a modifying factor in the etiology of AD. | Positive | Comment on Study |
Kanazawa, T., 2007 | SNP: rs6265 | The results indicate there is a lack of association between the Val66Met polymorphism of BDNF and either schizophrenia or bipolar disorder. | Negative | Comment on Study |
Gonzalez-Castro, T. B., 2014 | SNP: rs6265 | No significant associations were observed in all models and subgroups. | Negative | Comment on Study |
Tramontina, J., 2007 | Other variant: BDNF_Val66Met | No significant differences were found in the frequency of the BDNF val66met genotype or allele distribution between patients and controls. | Negative | Comment on Study |
Green, E. K., 2006 | Other variant: BDNF_Val66Met | Variation at the Val66Met polymorphism of BDNF does not play a major role in influencing susceptibility to bipolar disorder as a whole, but is associated with susceptibility to the rapid cycling subset of the disorder. | Positive | Comment on Study |
Kremeyer, B., 2006 | SNP: rs6265 Haplotype: rs6265 - BDNF_(CA)(Met-221), rs6265 - BDNF_(CA)(Met-223), rs6265 - BDNF_(CA)(Met-225), rs6265 - BDNF_(CA)(Met-227), rs6265 - BDNF_(CA)(Met-229), rs6265 - BDNF_(CA)(Met-231), rs6265 - BDNF_(CA)(Met-233), rs6265 - BDNF_(CA)(Val-219), rs6265 - BDNF_(CA)(Val-221), rs6265 - BDNF_(CA)(Val-223), rs6265 - BDNF_(CA)(Val-225), rs6265 - BDNF_(CA)(Val-227), rs6265 - BDNF_(CA)(Val-229), rs6265 - BDNF_(CA)(Val-231), rs6265 - BDNF_(CA)(Val-233) Other variant: BDNF_(CA) |
These results are consistent with previous studies pointing to a role for BDNF in susceptibility to mood disorders. | Positive | Comment on Study |
Muller, D. J., 2006 | SNP: rs2049045, rs2140887, rs3763965 Haplotype: BDNF_hCV11592756 - BDNF_Val66Met(A-G), BDNF_hCV11592756 - BDNF_Val66Met - BDNF_GT(n)(A-G-3), BDNF_hCV11592756 - BDNF_Val66Met - BDNF_GT(n) - rs2049045(A-G-3-G), BDNF_hCV11592756 - BDNF_Val66Met - rs2049045(A-G-G), BDNF_hCV11592756 - rs2049045(A-G), BDNF_Val66Met - BDNF_GT(n)(G-3) Other variant: BDNF_(GT)n, BDNF_hCV11592756, BDNF_Val66Met |
Within bipolar disorder, variation in the BDNF gene appears to predict risk for developing rapid cycling according toDSM-IV. Incorporating this clinical sub-phenotyping into other studies of the BDNF gene may help to resolve some of the inconsistencies reported thus far concerning BDNFand bipolar disorder. | Positive | Comment on Study |
Lohoff, F. W.,2005(c) | SNP: rs6265 | Results confirm previous findings and suggest that the Val allele increases risk for BPI in patients of European descent. | Positive | Comment on Study |
Yosifova, A.,2009 | SNP: rs2049045, rs4923463, rs6265 | Significant association of SNP in this gene with BD in our population was observed. | Positive | Comment on Study |
Mick, E.,2009 | Other variant: BDNF_Val66Met | We failed to identify an association with the val66 allele in BDNF with pediatric bipolar disorder.. | Negative | Comment on Study |
Xu, J., 2010 | SNP: rs6265 | We found that the BDNF genotype is associated with BPD in this population. | Positive | Comment on Study |
GO terms by PBA (count: 2)

ID | Name | Type | Evidence[PMID] | No. of Genes in BDgene |
---|---|---|---|---|
GO:0007411 | axon guidance | biological process | IEA | 60 |
GO:0007399 | nervous system development | biological process | TAS[2236018] | 40 |
GO terms by database search (count: 61)

KEGG pathways by PBA (count: 1)

ID | Name | No. of Genes in BDgene | Brief Description |
---|---|---|---|
hsa04010 | MAPK signaling pathway | 39 |
KEGG pathways by database search (count: 1)

ID | Name | No. of Genes in BDgene | Brief Description |
---|---|---|---|
hsa05040 | Huntington's disease | 6 |
Gene | Interactor | Interactor in BDgene? | Experiment Type | PMID |
---|---|---|---|---|
BDNF | MBTPS1 | NO | in vitro | 9990022 |
BDNF | SORT1 | NO | in vitro;in vivo | 15987945 |
BDNF | CPE | NO | in vitro | 15664176 |
BDNF | NTF3 | YES | in vitro | 7703225 |
BDNF | CADPS2 | NO | in vitro;in vivo | 14715936 |
BDNF | NOS3 | YES | in vitro | 10493752 |
Literature-origin SNPs (count: 20)

rs_ID | Location | Functional Annotation | No. of Studies (Positive/Negative/Trend) ![]() |
---|---|---|---|
rs11030102 | chr11:27660049 - 27660049(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant; upstream_gene_variant | 1(0/1/0) |
rs16917237 | chr11:27680836 - 27680836(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant | 1(1/0/0) |
rs1519480 | chr11:27654165 - 27654165(1) | downstream_gene_variant; intron_variant; non_coding_transcript_variant | 2(2/0/0) |
rs7934165 | chr11:27710436 - 27710436(1) | intron_variant; non_coding_transcript_variant | 1(0/1/0) |
rs2049045 | chr11:27672694 - 27672694(1) | intron_variant; NMD_transcript_variant; non_coding_transcript_variant | 3(2/1/0) |
rs4923463 | chr11:27650953 - 27650953(1) | downstream_gene_variant; intron_variant; non_coding_transcript_variant | 2(1/1/0) |
rs3763965 | chr11:27507440 - 27507440(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | 1(0/1/0) |
rs2883187 | chr11:27719545 - 27719545(1) | 5_prime_UTR_variant; intron_variant; non_coding_transcript_variant | 1(1/0/0) |
rs11030104 | chr11:27662970 - 27662970(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant; upstream_gene_variant | 2(1/1/0) |
rs2140887 | chr11:28019800 - 28019800(1) | downstream_gene_variant; upstream_gene_variant | 1(0/1/0) |
rs6265 | chr11:27658369 - 27658369(1) | 3_prime_UTR_variant; downstream_gene_variant; intron_variant; missense_variant; NMD_transcript_variant; non_coding_transcript_exon_variant; non_coding_transcript_variant | 17(7/10/0) |
rs988748 | chr11:27703198 - 27703198(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | 2(0/2/0) |
rs7103873 | chr11:27678770 - 27678770(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant | 1(0/1/0) |
rs7127507 | chr11:27693337 - 27693337(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant | 1(1/0/0) |
rs11030119 | chr11:27706555 - 27706555(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | 1(1/0/0) |
rs2030324 | chr11:27705368 - 27705368(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | 1(1/0/0) |
rs11030107 | chr11:27673288 - 27673288(1) | intron_variant; NMD_transcript_variant; non_coding_transcript_variant | 1(1/0/0) |
rs10835210 | chr11:27674363 - 27674363(1) | intron_variant; NMD_transcript_variant; non_coding_transcript_variant | 1(0/1/0) |
rs7103411 | chr11:27678578 - 27678578(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant | 2(0/2/0) |
rs12273363 | chr11:27723312 - 27723312(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | 3(2/1/0) |
LD-proxies (count: 17)

rs_ID | Literature-origin SNPs with LD | Location | Functional Annotation |
---|---|---|---|
rs7124442 | chr11:27655494 - 27655494(1) | 3_prime_UTR_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_exon_variant; non_coding_transcript_variant | |
rs10767658 | chr11:27650705 - 27650705(1) | downstream_gene_variant; intron_variant; non_coding_transcript_variant | |
rs11030121 | chr11:27714660 - 27714660(1) | intron_variant; non_coding_transcript_variant | |
rs962369 | chr11:27712873 - 27712873(1) | intron_variant; non_coding_transcript_variant | |
rs12288512 | chr11:27726124 - 27726124(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | |
rs1013402 | chr11:27690834 - 27690834(1) | intron_variant; NMD_transcript_variant; non_coding_transcript_variant | |
rs10835211 | chr11:27679818 - 27679818(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant | |
rs11030108 | chr11:27673917 - 27673917(1) | intron_variant; NMD_transcript_variant; non_coding_transcript_variant | |
rs1401635 | chr11:27672444 - 27672444(1) | intron_variant; NMD_transcript_variant; non_coding_transcript_variant | |
rs2030323 | chr11:27706992 - 27706992(1) | intron_variant; non_coding_transcript_variant | |
rs10767665 | chr11:27712311 - 27712311(1) | intron_variant; non_coding_transcript_variant | |
rs6484320 | chr11:27681641 - 27681641(1) | downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_variant | |
rs10767664 | chr11:27704439 - 27704439(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | |
rs7931247 | chr11:27725444 - 27725444(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | |
rs17309930 | chr11:27726946 - 27726946(1) | intron_variant; non_coding_transcript_variant; upstream_gene_variant | |
rs2049046 | chr11:27702228 - 27702228(1) | downstream_gene_variant; intron_variant; non_coding_transcript_variant; upstream_gene_variant | |
rs11030101 | chr11:27659197 - 27659197(1) | 5_prime_UTR_variant; downstream_gene_variant; intron_variant; NMD_transcript_variant; non_coding_transcript_exon_variant; non_coding_transcript_variant |
Variant Name | Variant Type | Location in Gene | No. of Studies (Positive/Negative/Trend) ![]() |
---|---|---|---|
BDNF_-1480C/G | point mutation | 1 (0/1/0) | |
BDNF_196G/A | point mutation | 3 (2/1/0) | |
BDNF_3071G/A | point mutation | 1 (0/1/0) | |
BDNF_-633T/A | point mutation | 1 (1/0/0) | |
BDNF_11757C/G | point mutation | 1 (1/0/0) | |
BDNF_12910C/A | point mutation | 1 (0/1/0) | |
BDNF_-1360C>T | point mutation | 1 (0/1/0) | |
BDNF_14569G/A | point mutation | 1 (1/0/0) | |
BDNF_g.11757C>G | point mutation | 1 (0/1/0) | |
BDNF_(GT)n | microsatellite | 3 (2/1/0) | |
BDNF_hCV11592756 | point mutation | 1 (1/0/0) | |
BDNF-LCPR | microsatellite | approximately 1.0 kb upstream of the translation initiation site of the BDNF gene | 2 (1/1/0) |
BDNF_9202G/A | point mutation | 1 (0/1/0) | |
BDNF_A-633T | point mutation | 1 (0/1/0) | |
BDNF_C270T | point mutation | 1 (0/1/0) | |
BDNF_(CA) | microsatellite | 1.3 kb away from rs6265 | 1 (0/1/0) |
BDNF_Val66Met | point mutation | 21 (11/10/0) |
Region Name | Position | No. of Studies (Positive/Negative/Trend) ![]() |
---|---|---|
Chr 11 | chr11:0-135086622 | 2 (0/2/0) |
11q14.3-11q21 | chr11:22000000-97400000 | 1 (0/0/1) |
Overlap with SZ from cross-disorder studies (count: 4)

Reference | Description | Result Category |
---|---|---|
17417060 | The results indicate there is a lack of association between the Val66Met polymorphism of BDNF and either schizophrenia or bipolar disorder. | Negative |
15630410 | Haplotype analysis of val/met SNP and a dinucleotide repeat polymorphism in the putative promoter region revealed highly significant (P<E-08) under-representation of the methionine or met-1 haplotype in the schizophrenic but not the BP population. | Positive |
16005437 | Our findings suggest that BDNF may be a susceptibility gene for MDD and schizophrenia—in particular, in a subgroup of patients with schizophrenia with a lifetime history of depressive symptoms. | Positive |
15543516 | No association was found between the studied polymorphism and schizophrenia or bipolar affective disorder either for genotype or allele distribution. | Negative |
Overlap with SZ from candidate gene intersection analysis (count: 47)

Reference | ID in SZGene | Result Category |
---|---|---|
9858028 | 2 | Negative |
14755448 | 2 | Trend |
19406621 | 2 | Negative |
16056149 | 2 | Negative |
16649215 | 2 | Negative |
19207030 | 2 | Positive |
19359449 | 2 | Negative |
15949651 | 2 | Negative |
16406671 | 2 | Negative |
20395113 | 2 | Negative |
19158809 | 2 | Negative |
15567073 | 2 | Negative |
16854566 | 2 | Negative |
11032392 | 2 | Positive |
20102668 | 2 | Negative |
15900221 | 2 | Negative |
16818862 | 2 | Positive |
14623369 | 2 | Positive |
20420877 | 2 | Negative |
16631352 | 2 | Negative |
17196936 | 2 | Positive |
17669628 | 2 | Negative |
15630410 | 2 | Positive |
17893707 | 2 | Negative |
12610646 | 2 | Positive |
12837526 | 2 | Positive |
15526143 | 2 | Negative |
19336781 | 2 | Negative |
15913964 | 2 | Negative |
17289348 | 2 | Negative |
12951204 | 2 | Trend |
16005437 | 2 | Positive |
9259382 | 2 | Negative |
19573260 | 2 | Negative |
16581172 | 2 | Negative |
19944766 | 2 | Negative |
20061032 | 2 | Negative |
12553913 | 2 | Negative |
16513879 | 2 | Positive |
10581496 | 2 | Negative |
11343865 | 2 | Negative |
15543516 | 2 | Negative |
17450558 | 2 | Negative |
16897602 | 2 | Positive |
17267117 | 2 | Negative |
20667458 | 2 | Negative |
16389585 | 2 | Positive |
Overlap with MDD from cross-disorder studies (count: 3)

Reference | Description | Category in MDD |
---|---|---|
21438144 | No significant association of this gene was observed in MDD. | Negative |
14673216 | Given the fact that the positive association between BDNF gene Val66Met polymorphism and bipolar disorder has only been demonstrated for a Caucasian population but not for a Japanese analog or our Chinese sample, it appears likely that this association is ethnicity dependent. | Negative |
16005437 | Our findings suggest that BDNF may be a susceptibility gene for MDD and schizophrenia—in particular, in a subgroup of patients with schizophrenia with a lifetime history of depressive symptoms. | Positive |
Overlap with MDD from candidate gene intersection analysis (count: 13)

Reference | Description | Category in MDD | Link in MK4MDD |
---|---|---|---|
21129438 | The analysis revealed a strong association between the BDNF G-712A genotype distribution and MD (p=0.0005). The frequency of the -712A allele was significantly higher in MD patients than in the healthy controls (p=0.0007). | Pos | BDNF |
21218562 | elderly MDD BDNF val/val homozygotes had significantly higher right hippocampal volumes compared with nondepressed val/val subjects. In addition, depressed met carriers had an earlier age of onset of depressive illness than val/val homozygotes | Pos | BDNF |
20033742 | Further gene-gene interaction analyses showed a significant effect of a two-locus BDNF/GSK3B interaction with MDD (GSK3B rs6782799 and BDNF rs7124442) (corrected P = 0.011), and also for a three-locus interaction (GSK3B rs6782799, BDNF rs6265 and BDNF rs7124442) (corrected P = 0.019). | Pos | BDNF |
23255668 | We found no significant association of either the BDNF G196A or MTHFR C677T polymorphisms with major depressive disorder neither in female nor male group of patients. | Neg | BDNF |
20016225 | In the multivariate regression analysis, there was no significant association between severity of depression and BDNF Val66Met polymorphism. | Neg | BDNF |
19414708 | Association analyses of patients with MDD and controls showed that 6 SNPs in this gene were associated with MDD (rs12273539, rs11030103, rs6265, rs28722151, rs41282918, and rs11030101) | Pos | BDNF |
19931400 | Significant effects of diagnosis and diagnosis-by-genotype interactions (F's>4, p's<0.05) characterized activations in amygdala and anterior hippocampal regions. Greater activations in patients than healthy adolescents were found. Critically, these hyperactivations were modulated by BDNF genotype: Met-carriers showed greater neural responses of emotional faces than Val/Val homozygotes in patients only. | Pos | BDNF |
22498307 | The MDD group showed significantly poorer performance than the control group in cognitive functions; they also had lower levels of BDNF than the control group. | Pos | BDNF |
22901293 | A signi?cant reduction of BDNF gene expression in MDD subjects (0.45, SD=10; p<.05, according to unpaired t test) versus controls(1.00, SD=21; Figure 1A)was observed. In addition, an increase of DNA methylation at BDNF gene promoter was observed in MDD patients, compared with control subjects (32.52% SD=2.03% vs.24.04% SD=2.08%; p <.05, according to unpaired t test; Figure 1B) | Pos | BDNF |
14582140 | No significant differences were demonstrated for the genotype or allele frequency of the BDNF polymorphism comparing the MDD and control groups. | Neg | BDNF |
19699537 | No significant associations with MDD were demonstrated for three SNPs. | Neg | BDNF |
Region: chr11:27654893..27722058 View in gBrowse
Copyright: Bioinformatics Lab, Institute of Psychology, Chinese Academy of Sciences Feedback
Acknowledgements
To view this website normally, please make sure to allow Flash to run from the local filesystem in the security settings panel.
Last update: March 31, 2016